Education
About Us
Working with TipRanks
Follow Us
Cannara Biotech, Inc. (LOVFF)
:LOVFF
LOVFF Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.39 - $1.05
Previous CloseN/A
Volume3.00K
Average Volume (3M)8.74K
Market Cap
$93.13M
Enterprise Value$171.12M
Total Cash (Recent Filing)C$5.06M
Total Debt (Recent Filing)C$48.86M
Price to Earnings (P/E)9.4
Beta0.27
Next Earnings
Jul 24, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.11
Shares Outstanding90,643,950
10 Day Avg. Volume10,704
30 Day Avg. Volume8,737
Financial Highlights & Ratios
PEG Ratio0.09
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Cannara Biotech News
PremiumCompany Announcements
Cannara Biotech Shines in Latest Earnings Call
PremiumCompany Announcements
Cannara Biotech Reports Record Q2 2025 Earnings
PremiumCompany Announcements
Cannara Biotech Achieves Record Q2 2025 Results Amid National Expansion
PremiumCompany Announcements
Cannara Biotech to Release Q2 2025 Financial ResultsPremiumCompany Announcements
Cannara Biotech Appoints Justin Cohen to Board of Directors
PremiumCompany Announcements
Cannara Biotech Enhances Financial Flexibility with Credit Facility Extension---
Options Prices
Currently, No data available
---
Ownership Overview
LOVFF FAQ
What was Cannara Biotech, Inc.’s price range in the past 12 months?
Cannara Biotech, Inc. lowest stock price was $0.39 and its highest was $1.05 in the past 12 months.
What is Cannara Biotech, Inc.’s market cap?
Cannara Biotech, Inc.’s market cap is $93.13M.
When is Cannara Biotech, Inc.’s upcoming earnings report date?
Cannara Biotech, Inc.’s upcoming earnings report date is Jul 24, 2025 which is in 81 days.
How were Cannara Biotech, Inc.’s earnings last quarter?
Cannara Biotech, Inc. released its earnings results on Apr 28, 2025. The company reported $0.027 earnings per share for the quarter, beating the consensus estimate of N/A by $0.027.
Is Cannara Biotech, Inc. overvalued?
According to Wall Street analysts Cannara Biotech, Inc.’s price is currently Overvalued.
Does Cannara Biotech, Inc. pay dividends?
Cannara Biotech, Inc. does not currently pay dividends.
What is Cannara Biotech, Inc.’s EPS estimate?
Cannara Biotech, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Cannara Biotech, Inc. have?
Cannara Biotech, Inc. has 90,643,950 shares outstanding.
What happened to Cannara Biotech, Inc.’s price movement after its last earnings report?
Cannara Biotech, Inc. reported an EPS of $0.027 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Cannara Biotech, Inc.?
Currently, no hedge funds are holding shares in LOVFF
---
Company Description
Cannara Biotech, Inc.
Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivated products in Canada. It also offers hemp-based CBD products through e-commerce platform. The company was incorporated in 2017 and is headquartered in Saint-Laurent, Canada.
---
LOVFF Earnings Call
Q2 2025
0:00 / 0:00
---
Technical Analysis
---